perugu_vada Posted December 15, 2020 Report Posted December 15, 2020 Vaccine maker Moderna is poised to win authorization for its COVID-19 vaccine days after Pfizer-BioNTech did the same. Data released Tuesday by the U.S. Food and Drug Administration confirmed that Moderna's vaccine appeared safe and highly effective in a study of more than 30,000 volunteers. Unlike Pfizer-BioNTech's vaccine, Moderna's will be given only to adults. The company has begun testing in teenagers but has not accumulated enough data to include in its authorization request to the FDA. An independent advisory committee to the FDA will review the data in an all-day meeting Thursday. If the Vaccines and Related Biological Products Advisory Committee decides that the vaccine's benefits outweigh its risks, the vaccine is likely to be authorized this week by the FDA commissioner. An independent advisory committee to the U.S. Centers for Disease Control and Prevention will review the data this weekend and will vote on whether to add the vaccine to the nation's vaccine schedule for adults. Then, as with Pfizer-BioNTech's vaccine, it will be distributed across the country, probably starting Monday. Quote
MiryalgudaMaruthiRao Posted December 15, 2020 Report Posted December 15, 2020 time to buy Airlines, CC and hotel stocks Quote
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.